Decoding the Immune Response Behind Moderna’s Personalized mRNA Cancer Vaccine

Wed, Mar 17 | 04:00 PM - 04:20 PM
Track 1

Session details:

Translational immunology behind Moderna’s personalized mRNA cancer vaccine, including vaccine-induced immune responses, biomarkers of activity, and insights into how this approach may overcome limitations of prior cancer vaccine strategies.

Industry Specific Content:
Science & Clinical Development
Track:
Track 1: Breakthroughs in Translational Science